How B-cells relate to common allergies
Part of Ear, nose & throat, Immune system & allergy, Lungs & breathing clinical trials.
This study looks at a type of immune cell (B regulatory cell) in the blood of people with and without allergies to pollens, house dust mites, or insect stings. It aims to help understand how these cells work in allergic disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You either have NO allergies to pollens, house dust mites, or insect venom (control group) OR have a doctor-diagnosed allergy to one of those (test group).
- You must not be pregnant.
- You cannot have an allergy to things other than pollens, house dust mites, or insect venom (if you have an allergy).
- You must be able to understand English explanations.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at IgE, a protein involved in allergic reactions, to better understand its role in different immune-related diseases. It aims to find out how different forms of IgE relate to health and disease, which may help improve diagnosis or treatment.
This study looks at your blood to find allergy-related antibodies if you have pollen allergies to grass or birch. It may help researchers better understand what in the immune system drives allergy symptoms.
This study looks at how beekeepers develop tolerance to bee venom over time, comparing people who are new to beekeeping, experienced beekeepers without allergies, and beekeepers who have had a recent allergic reaction. If you fall into one of these groups, you may be able to join and help researchers understand how the immune system adapts to bee stings.
This trial studies whether having strong reactions to a specific bee venom protein can make venom immunotherapy less effective. It may help doctors better predict who is at higher risk for therapy failure after bee stings.
This trial tests a venom immunotherapy for people allergic to bee or wasp stings. It aims to see how well the treatment works in everyday medical practice.
This study tests a treatment called Beltaven® for people with severe allergic reactions to bee, wasp, or hornet stings. It aims to see if the treatment is safe and helps prevent future reactions.
Hear when a new Pollen Allergy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.